287 related articles for article (PubMed ID: 11139798)
1. Gene therapy: recombinant adeno-associated virus vectors.
Smith-Arica JR; Bartlett JS
Curr Cardiol Rep; 2001 Jan; 3(1):43-9. PubMed ID: 11139798
[TBL] [Abstract][Full Text] [Related]
2. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
[TBL] [Abstract][Full Text] [Related]
3. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
4. Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials with Recombinant Adeno-Associated Viral Vectors: An Evolving Controversy.
Ertl HCJ; High KA
Hum Gene Ther; 2017 Apr; 28(4):328-337. PubMed ID: 28042943
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus and adeno-associated virus vectors.
Lai CM; Lai YK; Rakoczy PE
DNA Cell Biol; 2002 Dec; 21(12):895-913. PubMed ID: 12573049
[TBL] [Abstract][Full Text] [Related]
6. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
7. Adeno-Associated Virus Genome Interactions Important for Vector Production and Transduction.
Maurer AC; Weitzman MD
Hum Gene Ther; 2020 May; 31(9-10):499-511. PubMed ID: 32303138
[TBL] [Abstract][Full Text] [Related]
8. Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery.
Wang Q; Dong B; Firrman J; Roberts S; Moore AR; Cao W; Diao Y; Kapranov P; Xu R; Xiao W
Hum Gene Ther Methods; 2014 Aug; 25(4):261-8. PubMed ID: 25093498
[TBL] [Abstract][Full Text] [Related]
9. Production and purification of recombinant adeno-associated vectors.
Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
[TBL] [Abstract][Full Text] [Related]
10. Recombinant adeno-associated virus as delivery vector for gene therapy--a review.
Lu Y
Stem Cells Dev; 2004 Feb; 13(1):133-45. PubMed ID: 15068701
[TBL] [Abstract][Full Text] [Related]
11. Hot topics in adeno-associated virus as a gene transfer vector.
Zhao N; Liu DP; Liang CC
Mol Biotechnol; 2001 Nov; 19(3):229-37. PubMed ID: 11721619
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.
Grieger JC; Samulski RJ
Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890
[TBL] [Abstract][Full Text] [Related]
13. Novel strategy for generation and titration of recombinant adeno-associated virus vectors.
Shiau AL; Liu PS; Wu CL
J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.
Nicolson SC; Li C; Hirsch ML; Setola V; Samulski RJ
J Virol; 2016 Aug; 90(16):7019-7031. PubMed ID: 27147738
[TBL] [Abstract][Full Text] [Related]
15. [Recombinant adeno-associated virus vector related impurities].
Diao Y; Wang Q; Xiao W; Xu R
Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):717-23. PubMed ID: 21845838
[TBL] [Abstract][Full Text] [Related]
16. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
Shi W; Arnold GS; Bartlett JS
Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
[TBL] [Abstract][Full Text] [Related]
17. Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing.
de Alencastro G; Pekrun K; Valdmanis P; Tiffany M; Xu J; Kay MA
Hum Gene Ther; 2020 May; 31(9-10):553-564. PubMed ID: 32024384
[TBL] [Abstract][Full Text] [Related]
18. Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry.
Large EE; Silveria MA; Zane GM; Weerakoon O; Chapman MS
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372542
[TBL] [Abstract][Full Text] [Related]
19. A Novel Next-Generation Sequencing and Analysis Platform to Assess the Identity of Recombinant Adeno-Associated Viral Preparations from Viral DNA Extracts.
Guerin K; Rego M; Bourges D; Ersing I; Haery L; Harten DeMaio K; Sanders E; Tasissa M; Kostman M; Tillgren M; Makana Hanley L; Mueller I; Mitsopoulos A; Fan M
Hum Gene Ther; 2020 Jun; 31(11-12):664-678. PubMed ID: 32159396
[TBL] [Abstract][Full Text] [Related]
20. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy.
Grimm D; Kay MA
Curr Gene Ther; 2003 Aug; 3(4):281-304. PubMed ID: 12871018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
